Microdosing psychedelic substances in the workplace is becoming a growing trend, with some business leaders and entrepreneurs openly endorsing its benefits for creativity and well-being. However, despite testimonies and preliminary studies suggesting various advantages, there’s limited research on its impact in professional settings, and it remains illegal in many European countries.
- Entrepreneurs Nils Paar and Gino Taselaar of Microdose Pro, a company based in Amsterdam, advocate for the benefits of microdosing and have even taken their team on a retreat to experience psychedelics together.
- Prominent figures such as Elon Musk and Sergey Brin have discussed their experiences with microdosing substances like ketamine and magic mushrooms.
- Research indicates potential benefits of microdosing including enhanced creativity, focus, and well-being, with some users comparing it to a cup of coffee for productivity.
- The practice is controversial, with potential negative effects and the need for careful, intentional use. It also remains illegal in many places, limiting mainstream acceptance.
- While microdosing might not become commonplace in office environments soon, related products like nootropics with legal mushroom varieties are gaining traction.